RobertLanglandEilMD
General Surgery • Portland, ORHepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast), Minimally Invasive Surgery
Assistant Professor of Surgery & Cell, Developmental, and Cancer Biology
Dr. Eil is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Road
Portland, OR 97239Phone+1 503-494-5501
Summary
- Dr. Robert Eil is a general surgeon based in Portland, OR, with subspecialties in hepatobiliary surgery, pancreatic surgery, surgical oncology (excluding breast), and minimally invasive surgery. He completed fellowships in tumor immunology at the National Cancer Institute and complex general surgical oncology at Memorial Sloan Kettering Cancer Center. His surgical residency was at Oregon Health & Science University, where he is currently an Assistant Professor and Surgery Resident. Dr. Eil has published several research articles, focusing on topics such as pancreatic cancer, colorectal liver metastases, and immune responses in cancer treatment.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2018 - 2020
Oregon Health & Science University (OHSU Health)Residency, Surgery, 2016 - 2018
National Cancer InstituteFellowship, Tumor Immunology, 2013 - 2016- Oregon Health & Science University (OHSU Health)Residency, Surgery, 2010 - 2013
University of North Carolina at Chapel Hill School of MedicineClass of 2010
Certifications & Licensure
OR State Medical License 2013 - 2025
NY State Medical License 2017 - 2021
American Board of Surgery Surgery- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- Concurrent preoperative eribulin and radiation for resectable retroperitoneal liposarcoma: a phase 1B study.Lara Davis, Limin Zhu, Skye C Mayo, Emile Latour, Byung Park
Research Square. 2024-12-17 - A Modified Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion.Issac R Schwantes, Ranish K Patel, Adel Kardosh, Jillian Paxton, Robert Eil
Annals of Surgical Oncology. 2024-10-01 - Pancreatic cancer cells overexpressing interleukin 6 induce T-cell-mediated tumor clearance and durable anti-tumor immune response.Paige C Arneson-Wissink, Alexandra Q Bartlett, Heike Mendez, Xinxia Zhu, Jessica Dickie
Biorxiv. 2024-09-27
Press Mentions
OHSU Scientists Awarded Funding for Innovative Human Health ResearchFebruary 3rd, 2025
Grant Support
- Targeting an unrecognized checkpoint on T cell function in tumorsOREGON HEALTH & SCIENCE UNIVERSITY2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
